Recent Updates — VOGX

Richard Gorman joins Vogenx as Chief Commercial Officer effective October 12, 2026, leading commercial operations and corporate strategy for its pipeline. Concurrent with this appointment, Gorman resigns from the Board of Directors and all committees to focus on his new management role. The company will conduct a search for a new independent director. Vogenx is a clinical-stage biopharmaceutical company developing novel therapeutics for metabolic and gastrointestinal diseases.